New patent for Sanofi Aventis drug LANTUS SOLOSTAR

Annual Drug Patent Expirations for LANTUS+SOLOSTAR
Annual Drug Patent Expirations for LANTUS+SOLOSTAR

Lantus Solostar is a drug marketed by Sanofi Aventis Us
and is included in one NDA. It is available from six suppliers. There are eight patents protecting this drug.

This drug has one hundred and twenty-three patent family members in twenty-five countries.

The generic ingredient in LANTUS SOLOSTAR is insulin glargine recombinant. Six suppliers are listed for this compound. Additional details are available on the insulin glargine recombinant profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com